Treatment of a vasoproliferative tumour with intravitreal bevacizumab (Avastin)

被引：0
|
作者：
N Kenawy
C Groenwald
B Damato
机构：
[1] St Paul's Eye Unit,
[2] Royal Liverpool University Hospital,undefined
[3] St Paul's Eye Unit,undefined
[4] Royal Liverpool University Hospital,undefined
[5] Liverpool Ocular Oncology Center,undefined
[6] Royal Liverpool University Hospital,undefined
来源：
Eye | 2007年 / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：893 / 894
页数：1
相关论文
共 50 条
  • [41] Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
    Mesa Gutierrez, Juan Carlos
    Arias Barquet, Luis
    Caminal Mitjana, Josep Maria
    Prades Almolda, Sergi
    Planas Domenech, N-Ria
    Pujol Goita, Octavi
    Rubio Caso, Marc
    Arruga Ginebreda, Jorge
    CLINICAL OPHTHALMOLOGY, 2008, 2 (04): : 787 - 791
  • [42] Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia
    Yamamoto, Izumi
    Rogers, Adam H.
    Reichel, Elias
    Yates, Paul A.
    Duker, Jay S.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (02) : 157 - 160
  • [43] Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage
    Spaide, Richard F.
    Fisher, Yale L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (03): : 275 - 278
  • [44] Intravitreal bevacizumab (avastin) treatment of neovascular age-related macular degeneration
    Emerson, M. Vaughn
    Lauer, Andreas K.
    Flaxel, Christina J.
    Wilson, David J.
    Francis, Peter J.
    Stout, J. Timothy
    Emerson, Geoffrey G.
    Schlesinger, Thomas K.
    Nolte, Susan K.
    Klein, Michael L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (04): : 439 - 444
  • [45] Intravitreal bevacizumab (avastin) in treatment of neovascular age-related macular degeneration
    Lazic, Ratimir
    Gabric, Nikica
    Dekaris, Iva
    Saric, Borna
    Gavric, Morena
    COLLEGIUM ANTROPOLOGICUM, 2007, 31 : 77 - 81
  • [46] Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy
    Lai, T. Y. Y.
    Chan, W-M
    Liu, D. T. L.
    Luk, F. O. J.
    Lam, D. S. C.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (05) : 661 - 666
  • [47] The effect of intravitreal bevacizumab (avastin) administration on systemic hypertension
    Rasier, R.
    Artunay, O.
    Yuzbasioglu, E.
    Sengul, A.
    Bahcecioglu, H.
    EYE, 2009, 23 (08) : 1714 - 1718
  • [48] The effect of intravitreal bevacizumab (avastin) administration on systemic hypertension
    R Rasier
    O Artunay
    E Yuzbasioglu
    A Sengul
    H Bahcecioglu
    Eye, 2009, 23 : 1714 - 1718
  • [49] Acute endophthalmitis following intravitreal bevacizumab (Avastin) injection
    Aggio, F. B.
    Farah, M. E.
    de Melo, G. B.
    d'Azevedo, P. A.
    Pignatri, A. C. C.
    Hofling-Lima, A. L.
    EYE, 2007, 21 (03) : 408 - 409
  • [50] Effect of Intravitreal Bevacizumab (Avastin) on the Growing Rabbit Eye
    Axer-Siegel, Ruth
    Kremer, Israel
    Snir, Moshe
    Herscovici, Zvi
    Hasanreisoglu, Murat
    Benjamini, Yoav
    CURRENT EYE RESEARCH, 2009, 34 (08) : 660 - 665
12345